Oxytetracycline in Pyoderma.
One hundred patients with moderate to severe pyoderma were treated with oral oxytetracycline. The most common organism isolated were coagulase positive Staph pyogenes and Str betahemolyticus. Of 100 patients; 87 showed a successful therapeutic response. The predictive value of in vitro test for bacterial susceptibility to oxytetracycline (30 mcg disc) was 88% for "sensitive" reports but 17% for "resistant" reports.Judged by clinical response the incidence of false sensitive reports was 12% (9/87) but that of false resistant reports was 83 (22/26).